 | • レポートコード：MRC2302D100 • 出版社/出版日：Transparency Market Research / 2022年12月19日 • レポート形態：英語、PDF、130ページ • 納品方法：Eメール（受注後24時間以内） • 産業分類：医療 |
| Single User | ￥869,250 (USD5,795) | ▷ お問い合わせ |
| Multi User | ￥1,319,250 (USD8,795) | ▷ お問い合わせ |
| Corporate License | ￥1,769,250 (USD11,795) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| Transparency Market Research社の本調査資料では、2022年に76億ドルであった世界の歯周治療市場規模が2031年には122億ドルとなり、予測期間の間に年平均4.8％増加すると展望しています。本資料では、歯周治療の世界市場について徹底調査し、序論、仮定・調査方法、エグゼクティブサマリー、市場概要、主要インサイト、治療別（非外科治療、外科治療）分析、エンドユーザー別（病院、歯科医院、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米、中東・アフリカ）分析、競争状況などを掲載しています。本資料は、3M、AMD Lasers, Inc.、ASA Dental S.p.A,、Biolase, Inc.、Carl Martin GmbH、Danaher、Dentsply Sirona、Deppeler SA、Karl Schumacher、Medtronic、Novartis AG、Pfizer, Inc.、Planmeca Oy、Steris-Hu-Friedy、Straumann AGなどの企業情報を収録しています。 ・序論 ・仮定・調査方法 ・エグゼクティブサマリー ・市場概要 ・主要インサイト ・世界の歯周治療市場規模：治療別 - 非外科治療の市場規模 - 外科治療の市場規模 ・世界の歯周治療市場規模：エンドユーザー別 - 病院における市場規模 - 歯科医院における市場規模 - その他における市場規模 ・世界の歯周治療市場規模：地域別 - 北米の歯周治療市場規模 - ヨーロッパの歯周治療市場規模 - アジア太平洋の歯周治療市場規模 - 中南米の歯周治療市場規模 - 中東・アフリカの歯周治療市場規模 ・競争状況 ・仮定 ・調査手法 |
Periodontal Treatment Market – Scope of Report
TMR’s report on the global periodontal treatment market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2022 to 2031. The report provides revenue of the global periodontal treatment market for the period 2017–2031, considering 2021 as the base year and 2031 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global periodontal treatment market from 2022 to 2031.
The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the periodontal treatment market.
Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global periodontal treatment market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report sheds light on the changing competitive dynamics in the global periodontal treatment market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global periodontal treatment market.
The report delves into the competitive landscape of the global periodontal treatment market. Key players operating in the global periodontal treatment market have been identified and each one of these has been profiled, in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are attributes of players in the global periodontal treatment market profiled in this report.
RESEARCH METHODOLOGY
The research methodology will be a combination of exhaustive primary and secondary research to analyze the market periodontal treatment.
Secondary Research
Secondary research includes a search of company literature, technical writing, patent data, Internet sources, and statistical data from government websites, trade associations, and agencies. This has proven to be the most reliable, effective, and successful approach for obtaining precise data, capturing industry participants’ insights, and recognizing business opportunities.
Secondary research sources that we typically refer, but are not limited to:
Company websites, presentations, annual reports, white papers, technical paper, product brochure
Internal and external proprietary databases and relevant patents
National government documents, statistical databases, and market reports
News articles, press releases, and webcasts specific to companies operating in the market
Specific Secondary Sources:
Industry Sources:
WorldWideScience.org
Elsevier, Inc.
National Institutes of Health (NIH)
PubMed
NCBI
Department of Health Care Service
Trade Data Sources
Trade Map
UN Comtrade
Trade Atlas
Company Information
OneSource Business Browser
Hoover’s
Factiva
Bloomberg
Mergers & Acquisitions
Thomson Mergers & Acquisitions
MergerStat
Profound
Primary Research
During the course of research, we conduct in-depth interviews and discussions with a wide range of key industry participants and opinion leaders. Primary research represents bulk of research efforts, supplemented by extensive secondary research.
We conduct primary interviews on the ongoing basis with industry participants and commentators to validate data and analysis. A typical research interview fulfills the following functions:
Provides first-hand information on market size, market trends, growth trends, competitive landscape, outlook, etc.
Helps in validating and strengthening secondary research findings
Further develops the analysis team’s expertise and market understanding
Primary research involves e-mail interactions, telephonic interviews, as well as face-to-face interviews for each market, category, segment, and sub-segment across geographies
Participants who typically take part in such a process include, but are not limited to:
Industry participants: Marketing/product managers, market intelligence managers, and regional sales managers
Purchasing/Sourcing managers, technical personnel, distributors
Outside experts: Investment bankers, valuation experts, and research analysts specializing in specific markets
Key opinion leaders specializing in different areas corresponding to different industry verticals
List of primary participants, but not limited to:
Advanced Oncotherapy PLC
Danfysik A/S
Hitachi, Ltd.
IBA Worldwide
Mevion Medical Systems, Inc.
Data Triangulation: Information culled from “Secondary & Primary Sources” is cross-checked with “TMR Knowledge Repository”, which is updated every quarter.
Market Estimation: Market size estimations involved in-depth study of product features, technology updates, geographic presence, product demand, sales data (value or volume), historical year-on-year growth, and others. Other approaches were also utilized to derive market size and forecasts. Where no hard data was available, we employed modeling techniques in order to produce comprehensive datasets. A rigorous methodology has been adopted, wherein the available hard data are cross-referenced with the following data types to produce estimates:
Demographic Data: Healthcare expenditure, inflation rates, and others
Industry Indicators: R&D investment, technology stage, and infrastructure, sector growth, and facilities
Market Forecasting: Market forecasts for various segments are derived taking into account drivers, restraints/challenges, and opportunities prevailing in the market and considering advantages/disadvantages of segments/sub-segments over other segments/sub-segments. Business environment, historical sales pattern, unmet needs, competitive intensity, and country-wise surgery data are some of the other pivotal factors, which are considered to derive market forecasts.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Periodontal Treatment Market
4. Market Overview
4.1. Introduction
4.1.1. Definition
4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Periodontal Treatment Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Disease Prevalence & Incidence Rate globally with key countries
5.2. Key Industry Events (mergers & acquisitions, product launches, partnerships, etc.)
5.3. Overview on types and causes of Periodontal Disease
5.4. Outlook of Major Products used in Surgical and Non-surgical Treatment
5.5. Covid-19 Pandemic Impact on the Industry
6. Global Periodontal Treatment Market Analysis and Forecast, by Treatment Type
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Treatment Type, 2017–2031
6.3.1. Non-surgical Treatment
6.3.1.1. Scaling & Root Planning
6.3.1.2. Antibiotics
6.3.1.2.1. Systemic Antibiotics
6.3.1.2.2. Local Antibiotics
6.3.2. Surgical Treatment
6.3.2.1. Pocket Reduction Surgery
6.3.2.2. Soft Tissue Grafts
6.3.2.3. Bone Grafts
6.3.2.4. Others
6.4. Market Attractiveness Analysis, by Treatment Type
7. Global Periodontal Treatment Market Analysis and Forecast, by End-user
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by End-user, 2017–2031
7.3.1. Hospitals
7.3.2. Dental Clinics
7.3.3. Others
7.4. Market Attractiveness Analysis, by End-user
8. Global Periodontal Treatment Market Analysis and Forecast, by Region
8.1. Key Findings
8.2. Market Value Forecast, by Region
8.2.1. North America
8.2.2. Europe
8.2.3. Asia Pacific
8.2.4. Latin America
8.2.5. Middle East & Africa
8.3. Market Attractiveness Analysis, by Region
9. North America Periodontal Treatment Market Analysis and Forecast
9.1. Introduction
9.1.1. Key Findings
9.2. Market Value Forecast, by Treatment Type, 2017–2031
9.2.1. Non-surgical Treatment
9.2.1.1. Scaling & Root Planning
9.2.1.2. Antibiotics
9.2.1.2.1. Systemic Antibiotics
9.2.1.2.2. Local Antibiotics
9.2.2. Surgical Treatment
9.2.2.1. Pocket Reduction Surgery
9.2.2.2. Soft Tissue Grafts
9.2.2.3. Bone Grafts
9.2.2.4. Others
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Dental Clinics
9.3.3. Others
9.4. Market Value Forecast, by Country, 2017–2031
9.4.1. U.S.
9.4.2. Canada
9.5. Market Attractiveness Analysis
9.5.1. By Treatment Type
9.5.2. By End-user
9.5.3. By Country
10. Europe Periodontal Treatment Market Analysis and Forecast
10.1. Introduction
10.1.1. Key Findings
10.2. Market Value Forecast, by Treatment Type, 2017–2031
10.2.1. Non-surgical Treatment
10.2.1.1. Scaling & Root Planning
10.2.1.2. Antibiotics
10.2.1.2.1. Systemic Antibiotics
10.2.1.2.2. Local Antibiotics
10.2.2. Surgical Treatment
10.2.2.1. Pocket Reduction Surgery
10.2.2.2. Soft Tissue Grafts
10.2.2.3. Bone Grafts
10.2.2.4. Others
10.3. Market Value Forecast, by End-user, 2017–2031
10.3.1. Hospitals
10.3.2. Dental Clinics
10.3.3. Others
10.4. Market Value Forecast, by Country/Sub-region, 2017–2031
10.4.1. Germany
10.4.2. U.K.
10.4.3. France
10.4.4. Spain
10.4.5. Italy
10.4.6. Rest of Europe
10.5. Market Attractiveness Analysis
10.5.1. By Treatment Type
10.5.2. By End-user
10.5.3. By Country/Sub-region
11. Asia Pacific Periodontal Treatment Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Treatment Type, 2017–2031
11.2.1. Non-surgical Treatment
11.2.1.1. Scaling & Root Planning
11.2.1.2. Antibiotics
11.2.1.2.1. Systemic Antibiotics
11.2.1.2.2. Local Antibiotics
11.2.2. Surgical Treatment
11.2.2.1. Pocket Reduction Surgery
11.2.2.2. Soft Tissue Grafts
11.2.2.3. Bone Grafts
11.2.2.4. Others
11.3. Market Value Forecast, by End-user, 2017–2031
11.3.1. Hospitals
11.3.2. Dental Clinics
11.3.3. Others
11.4. Market Value Forecast, by Country/Sub-region, 2017–2031
11.4.1. China
11.4.2. Japan
11.4.3. India
11.4.4. Australia & New Zealand
11.4.5. Rest of Asia Pacific
11.5. Market Attractiveness Analysis
11.5.1. By Treatment Type
11.5.2. By End-user
11.5.3. By Country/Sub-region
12. Latin America Periodontal Treatment Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Treatment Type, 2017–2031
12.2.1. Non-surgical Treatment
12.2.1.1. Scaling & Root Planning
12.2.1.2. Antibiotics
12.2.1.2.1. Systemic Antibiotics
12.2.1.2.2. Local Antibiotics
12.2.2. Surgical Treatment
12.2.2.1. Pocket Reduction Surgery
12.2.2.2. Soft Tissue Grafts
12.2.2.3. Bone Grafts
12.2.2.4. Others
12.3. Market Value Forecast, by End-user, 2017–2031
12.3.1. Hospitals
12.3.2. Dental Clinics
12.3.3. Others
12.4. Market Value Forecast, by Country/Sub-region, 2017–2031
12.4.1. Brazil
12.4.2. Mexico
12.4.3. Rest of Latin America
12.5. Market Attractiveness Analysis
12.5.1. By Treatment Type
12.5.2. By End-user
12.5.3. By Country/Sub-region
13. Middle East & Africa Periodontal Treatment Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Treatment Type, 2017–2031
13.2.1. Non-surgical Treatment
13.2.1.1. Scaling & Root Planning
13.2.1.2. Antibiotics
13.2.1.2.1. Systemic Antibiotics
13.2.1.2.2. Local Antibiotics
13.2.2. Surgical Treatment
13.2.2.1. Pocket Reduction Surgery
13.2.2.2. Soft Tissue Grafts
13.2.2.3. Bone Grafts
13.2.2.4. Others
13.3. Market Value Forecast, by End-user, 2017–2031
13.3.1. Hospitals
13.3.2. Dental Clinics
13.3.3. Others
13.4. Market Value Forecast, by Country/Sub-region, 2017–2031
13.4.1. GCC Countries
13.4.2. South Africa
13.4.3. Rest of Middle East & Africa
13.5. Market Attractiveness Analysis
13.5.1. By Treatment Type
13.5.2. By End-user
13.5.3. By Country/Sub-region
14. Competition Landscape
14.1. Market Player – Competition Matrix (by tier and size of companies)
14.2. Market Share/Ranking Analysis, by Company, (2021)
14.3. Company Profiles
14.3.1. 3M
14.3.1.1. Company Overview
14.3.1.2. Product Portfolio
14.3.1.3. SWOT Analysis
14.3.1.4. Strategic Overview
14.3.2. AMD Lasers, Inc.
14.3.2.1. Company Overview
14.3.2.2. Product Portfolio
14.3.2.3. SWOT Analysis
14.3.2.4. Strategic Overview
14.3.3. ASA Dental S.p.A.
14.3.3.1. Company Overview
14.3.3.2. Product Portfolio
14.3.3.3. SWOT Analysis
14.3.3.4. Strategic Overview
14.3.4. Biolase, Inc.
14.3.4.1. Company Overview
14.3.4.2. Product Portfolio
14.3.4.3. SWOT Analysis
14.3.4.4. Strategic Overview
14.3.5. Carl Martin GmbH
14.3.5.1. Company Overview
14.3.5.2. Product Portfolio
14.3.5.3. SWOT Analysis
14.3.5.4. Strategic Overview
14.3.6. Danaher
14.3.6.1. Company Overview
14.3.6.2. Product Portfolio
14.3.6.3. SWOT Analysis
14.3.6.4. Strategic Overview
14.3.7. Dentsply Sirona
14.3.7.1. Company Overview
14.3.7.2. Product Portfolio
14.3.7.3. SWOT Analysis
14.3.7.4. Strategic Overview
14.3.8. Deppeler SA
14.3.8.1. Company Overview
14.3.8.2. Product Portfolio
14.3.8.3. SWOT Analysis
14.3.8.4. Strategic Overview
14.3.9. Karl Schumacher
14.3.9.1. Company Overview
14.3.9.2. Product Portfolio
14.3.9.3. SWOT Analysis
14.3.9.4. Strategic Overview
14.3.10. Medtronic
14.3.10.1. Company Overview
14.3.10.2. Product Portfolio
14.3.10.3. SWOT Analysis
14.3.10.4. Strategic Overview
14.3.11. Novartis AG
14.3.11.1. Company Overview
14.3.11.2. Product Portfolio
14.3.11.3. SWOT Analysis
14.3.11.4. Strategic Overview
14.3.12. Pfizer, Inc.
14.3.12.1. Company Overview
14.3.12.2. Product Portfolio
14.3.12.3. SWOT Analysis
14.3.12.4. Strategic Overview
14.3.13. Planmeca Oy
14.3.13.1. Company Overview
14.3.13.2. Product Portfolio
14.3.13.3. SWOT Analysis
14.3.13.4. Strategic Overview
14.3.14. Steris-Hu-Friedy
14.3.14.1. Company Overview
14.3.14.2. Product Portfolio
14.3.14.3. SWOT Analysis
14.3.14.4. Strategic Overview
14.3.15. Straumann AG
14.3.15.1. Company Overview
14.3.15.2. Product Portfolio
14.3.15.3. SWOT Analysis
14.3.15.4. Strategic Overview